Twin Tree Management
LFCR icon

Twin Tree Management’s Lifecore Biomedical LFCR Stock Holding History

Twin Tree Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-295
Closed -$3K – 1460
2018
Q4 		$3K Buy
+295
New +$4.05K ﹤0.01% 1255

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Twin Tree Management's LFCR Position: Q1 2019 in Review

Twin Tree Management sold out of Lifecore Biomedical (LFCR) in Q1 2019, closing a stake of 295 shares — an estimated $3K sold.

Twin Tree Management first reported a position in LFCR in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 91 funds tracked by Wall St. Rank hold LFCR as of Q1 2019.

  • Twin Tree Management reported no remaining Lifecore Biomedical position as of Q1 2019 after selling out during the quarter.
  • Twin Tree Management sold 295 Lifecore Biomedical shares in Q1 2019, an estimated $3K.
  • Twin Tree Management first reported a position in Lifecore Biomedical in Q4 2018 and held it in 1 quarter.
  • Twin Tree Management's Lifecore Biomedical position peaked at $3K in Q4 2018.
  • 91 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2019.

Based on Twin Tree Management's 13F filing for Q1 2019, filed 10 May 2019.